| 缩写 | 全称 | 中文释义 |
|---|---|---|
| FTR | Federal Travel Regulations | 联邦旅行条例 |
| NDMS | New Drug Microbiology Staff | 新药微生物学人员 |
| PRMB (CDER) | Program and Resources Management Branch (CDER) | 计划与资源管理分公司(CDER) |
| OBQI/M | Outcome-Based Quality Improvement/Monitoring | 基于结果的质量改进/监控 |
| PMS | Post-Marketing Surveillance | 上市后监督 |
| FD-483 | FDA form, Written Notice of Deficiencies Found in Inspections | FDA表格,检查中发现缺陷的书面通知 |
| SCSB | Scientific Computer Support Branch | 科学计算机支持分公司 |
| DRS | Drug-Resistance Survey | 抗药性调查 |
| Subpart H | That subpart of 21 CFR Part 314 pertaining to accelerated approval of drugs | 《美国联邦法规》第21编第314部分中与药品加速批准有关的子部分 |
| PAB (CFSAN) | Product Adulteration Branch (CFSAN) | 产品掺假处 |